Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

26
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
26
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

17
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
17
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

26
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
26
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

25
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
25
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

4.4K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.4K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

15
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
15

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Community Pharmacist Perspectives on Observing and Dispensing Methadone for Opioid Use Disorder: Cross-sectional Survey Study.

Journal of addiction medicine·2026
Same author

Evaluating demographic variation in no-cost naloxone distribution in North Carolina: a cross-sectional survey study.

Harm reduction journal·2026
Same author

Pilot evaluation of a pharmacist-led technical assistance program to address buprenorphine dispensing in community pharmacies.

Exploratory research in clinical and social pharmacy·2026
Same author

Methadone in community pharmacies: A mixed methods study of board-certified addiction medicine physician and addiction psychiatrist perspectives.

Journal of substance use and addiction treatment·2026
Same author

Barriers and facilitators to pharmacy-based methadone dosing and dispensing: Semi-structured interviews with pharmacists.

Journal of the American Pharmacists Association : JAPhA·2026
Same author

Overcoming Barriers to Health Care during Reentry with the North Carolina Formerly Incarcerated Transition (NC FIT) Program: Patient Perspectives.

Journal of health care for the poor and underserved·2026

Related Experiment Video

Updated: Sep 8, 2025

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

7.0K

"It Eats My Heart": Identifying Knowledge Gaps in Injection Drug-Related Endocarditis Among Hospitalized Patients.

Kate E A Roberts1,2, Eunice A Okumu3, Bailey McInnes3

  • 1Graduate School of Social Work and Social Research, Bryn Mawr College, Bryn Mawr, PA, USA.

Substance Use & Addiction Journal
|July 22, 2025
PubMed
Summary

Patients who inject drugs often lack knowledge about infective endocarditis (IE) and its prevention. Public health efforts should prioritize educating this population on IE risks and providing sterile injection equipment to prevent infections.

Keywords:
infectious diseasesinfective endocarditisinjection drug usepublic health medicine

More Related Videos

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
07:20

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Published on: February 10, 2023

1.4K
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

16.0K

Related Experiment Videos

Last Updated: Sep 8, 2025

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

7.0K
Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
07:20

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Published on: February 10, 2023

1.4K
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

16.0K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Addiction Medicine

Background:

  • Infective endocarditis (IE) rates are increasing, largely due to injection drug use (IDU).
  • Current public health interventions for IDU focus on communicable diseases like HIV and viral hepatitis, neglecting IE.
  • This study assesses IE knowledge among individuals with IDU-related IE.

Purpose of the Study:

  • To evaluate the awareness and understanding of infective endocarditis (IE) among patients with a history of injection drug use (IDU).
  • To explore the relationship between IE knowledge and IDU practices.
  • To identify gaps in public health messaging regarding IE prevention in the IDU population.

Main Methods:

  • Conducted semi-structured interviews with 16 adults hospitalized for IDU-related IE.
  • Interviews explored participants' knowledge and experiences with IE and IDU.
  • Data were audio-recorded, transcribed, and thematically coded.

Main Results:

  • Identified themes: limited IE knowledge, nonspecific IE symptoms, injection behaviors, and knowledge of other IDU infections (HCV, HIV).
  • Most patients had little IE knowledge pre-hospitalization, despite prior soft tissue infections.
  • Patients often delayed seeking care due to unrecognized IE symptoms; many reused injection equipment despite awareness of risks.

Conclusions:

  • Individuals who inject drugs and acquire IE demonstrate limited prior knowledge of the condition, its symptoms, and prevention strategies.
  • There is a critical need for public health campaigns to educate on preventing IE in persons who inject drugs.
  • Improved access to sterile injection equipment is essential to reduce the incidence of bacterial infections associated with IDU.